Savara Inc Income (Loss) from Continuing Operations before Income Taxes, Domestic
Savara Inc (SVRA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$84.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-13
- Savara Inc income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$84.30M.
- Savara Inc income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$63.26M.
- Savara Inc income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$40.83M.
- Savara Inc income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$29.33M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$84.30M 10-K · filed 2026-03-13 |
| 2024-12-31 | -$63.26M 10-K · filed 2026-03-13 |
| 2023-12-31 | -$40.83M 10-K · filed 2025-03-27 |
| 2022-12-31 | -$29.33M 10-K · filed 2024-03-07 |
| 2021-12-31 | -$28.70M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$30.40M 10-K · filed 2022-03-30 |
| 2019-12-31 | -$52.44M 10-K · filed 2021-03-10 |
| 2018-12-31 | -$48.87M 10-K · filed 2020-03-12 |
| 2017-12-31 | -$21.94M 10-K · filed 2019-03-13 |
| 2016-12-31 | -$8.50M 10-K · filed 2018-03-14 |
| 2015-12-31 | -$9.00M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |